News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dr. Ada Braun Joins Biothera As Chief Medical Officer


3/4/2014 8:20:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Biothera announced today the appointment of Ada H. Braun, M.D., Ph.D. as Chief Medical Officer responsible for the clinical and regulatory development of Imprime PGG®, the company’s Phase 3 cancer immunotherapy drug. Most recently, Dr. Braun was Executive Medical Director, Global Development, Hematology/Oncology at Amgen, Inc.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
Biothera
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES